LTC providers ‘win’ with new regs on drug repackaging, group says
Published by McKnight’s
Guidance on medication repackaging recently published by the U.S. Food and Drug Administration is earning praise from one long-term care pharmacy group, which says the final guidelines help reduce drug-related risks for residents.
The final guidance, published Thursday, included the elimination of a proposed 14-day limit on pre-packaging medications that could have put residents at risk and added significant compliance costs for long-term care pharmacies, the Senior Care Pharmacy Coalition said. Long-term care pharmacies can repackage medications under the final guidance, as long as the drugs do not leave the pharmacy without a patient-specific prescription or chart order.
The FDA’s guidelines also permit long-term care pharmacies to continue to use remote dispensing technology, and supply non-sterile products to facilities in emergency kits.
“The Agency heard our concerns about the unintended consequences of its original draft and agreed to exercise enforcement discretion to permit needed medication packaging and emergency kit practices to continue,” said Alan G. Rosenbloom, president and CEO of SCPC.
Rosenbloom added that the FDA’s guidance “represents a strong start for the LTC pharmacy sector in 2017, and more broadly recognizes LTC pharmacies’ unique value in the U.S. health care continuum.”
Click here to see the original article on the McKnight’s website.
Recent Posts
-
SCPC Releases Statement in Support of Government Accountability Office (GAO) Report on the Inflation Reduction Act
SCPC has repeatedly warned about the impact of the Inflation Reduction Act’s (IRA) mandatory Medicare drug price negotiations on LTC pharmacies and the millions of vulnerable seniors they serve. We are glad the Government Accountability Office (GAO) is examining how these policies are affecting pharmacies, particularly LTC pharmacies, which already operate under a broken reimbursement model that often requires them to dispense many of the most commonly used medications at a loss.
-
SCPC Applauds President Trump’s Executive Order Calling on HHS and Congress to Improve the IRA, Rein In PBMs and Lower Drug Costs
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care (LTC) pharmacy community, released the following statement applauding President Trump’s recent Executive Order aimed at improving the Inflation Reduction Act (IRA), lowering drug prices and addressing the harmful actions of PBMs. “For far too long, pharmacy benefit managers (PBMs) have taken […]
-
60 percent of LTC pharmacies warn of closure amid major drug pricing changes
Facing deep losses on high-demand medications, 85% of long-term care pharmacies say they will limit essential services and 60% will close locations without changes to Medicare drug pricing efforts. Those are among the “unintended consequences” revealed in a Senior Care Pharmacy Coalition survey released Wednesday. The trade association has been increasingly vocal about pricing changes set to go into effect in January.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.